SenesTech (NASDAQ:SNES) Earns Sell Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of SenesTech (NASDAQ:SNES) in a research report report published on Friday morning. The firm issued a sell rating on the stock.

SenesTech Stock Down 7.5 %

Shares of NASDAQ:SNES opened at $2.59 on Friday. SenesTech has a 12 month low of $1.90 and a 12 month high of $45.60. The company has a current ratio of 4.68, a quick ratio of 3.49 and a debt-to-equity ratio of 0.05. The company’s fifty day moving average price is $2.76 and its 200 day moving average price is $4.92.

SenesTech (NASDAQ:SNES) last posted its earnings results on Thursday, August 8th. The company reported ($3.08) EPS for the quarter, topping analysts’ consensus estimates of ($3.20) by $0.12. The business had revenue of $0.46 million for the quarter, compared to analysts’ expectations of $0.49 million. SenesTech had a negative return on equity of 168.64% and a negative net margin of 464.09%. During the same quarter in the previous year, the firm earned ($84.03) earnings per share. On average, equities research analysts anticipate that SenesTech will post -11 EPS for the current fiscal year.

SenesTech Company Profile

SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.